Surgery Partners, Inc. SGRY
Set alert
23.18 USD +0.06 +0.25%
As of Nov 3, 1:49 PM ET
23.17 Day range 23.22
11.41 52-week range 23.37
- YTD
- +50.01%
- 1 year
- +6.81%
- Open
- 23.19
- Prev close
- 23.12
- Mkt cap
- 2.99B
- Vol
- 785.54K
- Avg vol
- 3.40M
- EPS
- -0.69
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 23.17
- High
- 23.22
- Forward P/E
- 111.07
- Beta
- 1.88
- Short ratio
- 6.88
- Inst. own
- 128.71%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Nov 9, 2026
- 50-d avg
- 15.13
- 200-d avg
- 14.63
- 1y target
- 21.70
1Y chart
Events in this range
- Nov 10, 2025Earnings: 0.13; estimate 0.19; surprise -31.58%
- Mar 2, 2026Earnings: 0.12; estimate 0.31; surprise -61.29%
- May 5, 2026Earnings: -0.03; estimate -0.15; surprise 80%
- Aug 10, 2026Earnings: 0.1; estimate 0.05794; surprise 72.59%
- Aug 11, 2026Rating: TD Cowen · Buy → Buy
- Sep 14, 2026Rating: JP Morgan · Neutral → Neutral
- Sep 18, 2026Rating: TD Cowen · Buy → Buy
- Sep 30, 2026Rating: RBC Capital · Outperform → Outperform
- Oct 27, 2026Downgrade: StoneX · Buy → Hold
- Oct 28, 2026Downgrade: UBS · Buy → Neutral
Signals (61)
| Name | Date | Ago |
|---|---|---|
| RSI: Overbought | Oct 26, 2026 | 1 week ago |
| SMA: Bullish | Oct 13, 2026 | 3 weeks ago |
| SMA: Bullish | Oct 13, 2026 | 3 weeks ago |
| MACD: Buy Signal | Oct 12, 2026 | 3 weeks ago |
| MACD: Sell Signal | Oct 1, 2026 | 1 month ago |
| SMA: Bearish | Sep 29, 2026 | 1 month ago |
| SMA: Bearish | Sep 29, 2026 | 1 month ago |
| SMA: Bullish | Sep 28, 2026 | 1 month ago |
| SMA: Bullish | Sep 28, 2026 | 1 month ago |
| SMA: Bearish | Sep 23, 2026 | 1 month ago |
| SMA: Bearish | Sep 23, 2026 | 1 month ago |
| SMA: Bullish | Sep 22, 2026 | 1 month ago |
| SMA: Bullish | Sep 22, 2026 | 1 month ago |
| MACD: Buy Signal | Sep 22, 2026 | 1 month ago |
| MACD: Sell Signal | Sep 17, 2026 | 1 month ago |
| MACD: Buy Signal | Sep 1, 2026 | 2 months ago |
| SMA: Bullish | Aug 12, 2026 | 2 months ago |
| SMA: Bearish | Aug 11, 2026 | 2 months ago |
| SMA: Bearish | Aug 11, 2026 | 2 months ago |
| SMA: Bullish | Aug 7, 2026 | 2 months ago |
Newest 20 of 61.
Key statistics
- Market cap
- 2.98B
- Enterprise value
- 8.66B
- Trailing P/E
- 0.00
- Forward P/E
- 111.07
- PEG ratio
- 0.00
- Price / sales
- 0.89
- Price / book
- 1.79
- EPS (TTM)
- -0.69
- Beta
- 1.88
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Profit margin
- -2.63%
- Revenue (TTM)
- 3.37B
- Revenue growth
- 2.70%
- Free cash flow
- 183.56M
- Total cash
- 216.70M
- Total debt
- 4.07B
- Return on equity
- 2.32%
- Shares outstanding
- 128.87M
- Short % of float
- 21.69%
- 50-day average
- 15.13
- 200-day average
- 14.63
Analyst view
Consensus: buy
Buy
Price target (mean) 21.70 -6.4% downside
Now 23.18
- Target (low)
- 19.00
- Target (mean)
- 21.70
- Target (high)
- 23.50
Ratings (0m) 7 2 buy · 5 hold · 0 sell
- Strong buy0
- Buy2
- Hold5
- Sell0
- Strong sell0
Next earnings
Nov 9, 2026
Expected Nov 9, 2026. Consensus EPS estimate 0.12467.
Financials — quick view
SGRY Revenue — quarterly 848.90M
SGRY Net income — quarterly -15.00M
SGRY EPS — quarterly -0.12
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Nov 9, 2026 | Sep 30, 2026 | 0.1106 | — | — | — |
| Aug 10, 2026 | Jun 30, 2026 | 0.05794 | 0.10 | +0.04 | +72.59% |
| May 5, 2026 | Mar 31, 2026 | -0.15 | -0.03 | +0.12 | +80.00% |
| Mar 2, 2026 | Dec 31, 2025 | 0.31 | 0.12 | -0.19 | -61.29% |
| Nov 10, 2025 | Sep 30, 2025 | 0.19 | 0.13 | -0.06 | -31.58% |
| Aug 5, 2025 | Jun 30, 2025 | 0.16 | 0.17 | +0.01 | +6.25% |
Upgrades / downgrades
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Oct 28, 2026 | UBS | down | Buy | Neutral |
| Oct 27, 2026 | StoneX | down | Buy | Hold |
| Sep 30, 2026 | RBC Capital | reit | Outperform | Outperform |
| Sep 18, 2026 | TD Cowen | reit | Buy | Buy |
| Sep 14, 2026 | JP Morgan | main | Neutral | Neutral |
| Aug 11, 2026 | TD Cowen | main | Buy | Buy |
About Surgery Partners, Inc.
Surgery Partners, Inc., together with its subsidiaries, owns and operates a network of surgical facilities and ancillary services in the United States. The company provides ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including orthopedics and pain management, ophthalmology, gastroenterology, and general surgery. It offers emergency departments; ancillary services such as physician practices and diagnostic testing; multi-specialty physician practices; urgent care facilities; and anesthesia services. In addition, it offers single- and multi-specialty facilities. Surgery Partners, Inc. was founded in 2004 and is headquartered in Brentwood, Tennessee.
- Sector
- Healthcare
- Industry
- Medical Care Facilities
- Country
- United States
- Website
- surgerypartners.com
News
- SGRY Shareholder Notice: Surgery Partners $23.50 per Share Merger Under Investigation on Behalf of Shareholders
- SURGERY PARTNERS, INC. INVESTOR ALERT: Scott+Scott Attorneys at Law LLP Investigates Surgery Partners, Inc.'s Directors for Breach of Fiduciary Duties – SGRY
- SGRY Legal Notice: Surgery Partners Shareholders Are Notified to Contact BFA Law About the Ongoing Investigation Into the $23.50 Per Share Merger
- SGRY Investigation Reminder: Surgery Partners' $23.50 per Share Merger Is Under Investigation – Contact BFA Law if You Hold Shares
- SGRY Merger Notice: BFA Law Notifies Surgery Partners Shareholders of the Ongoing Investigation into the $23.50 per Share Merger
- UBS Downgrades Surgery Partners to Neutral, Raises Price Target to $23.5
- $HAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Surgery Partners, Inc. (NASDAQ: SGRY)
- Surgery Partners Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Surgery Partners, Inc. - SGRY
- SGRY Stock Notification: Surgery Partners, Inc. is being Investigated after the $23.50 per share Merger Deal Announced – Investors are Alerted to Contact BFA Law
- SGRY Investors Have Opportunity to Join Surgery Partners, Inc. Fraud Investigation with SBS Law
Your note
Sign in to keep a note on SGRY — it syncs with the Stock Master app.
Insider holders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| BALDOCK JENNIFER BOYD | Officer | Sale | Mar 11, 2026 | 326,474 |
| BANE HARRISON R | Officer | Sale | Sep 3, 2025 | 117,181 |
| BRITTENHAM MARISSA | Officer | Sale | Mar 12, 2026 | 94,196 |
| BURKHALTER DANIELLE | Officer | Sale | Mar 12, 2026 | 76,864 |
| DEVEYDT WAYNE S | Officer and Director | Stock Award(Grant) | Mar 20, 2025 | 105,203 |
| DOHERTY DAVID T. | Chief Financial Officer | Sale | Mar 15, 2026 | 221,679 |
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Bain Capital Investors Llc | 38.15% | 49,946,972 | 1.15B | Jun 29, 2026 |
| Jupiter Topco LLC | 10.60% | 13,882,155 | 320.96M | Jun 29, 2026 |
| Pentwater Capital Management Lp | 8.88% | 11,630,000 | 268.89M | Jun 29, 2026 |
| UBS Group AG | 6.55% | 8,573,413 | 198.22M | Jun 29, 2026 |
| Blackrock Inc. | 4.77% | 6,241,503 | 144.30M | Jun 29, 2026 |
| King Street Capital Management, LP | 4.63% | 6,058,141 | 140.06M | Jun 29, 2026 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| JANUS INVESTMENT FUND-Janus Henderson Contrarian Fund | 10.13% | 13,258,236 | 306.53M | Jun 29, 2026 |
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 1.90% | 2,481,034 | 57.36M | Jun 29, 2026 |
| T. Rowe Price Small-Cap Stock Fund, Inc. | 1.60% | 2,097,590 | 48.50M | Jun 29, 2026 |
| iShares Trust-iShares Russell 2000 ETF | 1.58% | 2,063,090 | 47.70M | Sep 29, 2026 |
| VANGUARD INDEX FUNDS-Vanguard Small-Cap Index Fund | 1.37% | 1,798,439 | 41.58M | Jun 29, 2026 |
| Legg Mason Partners Investment Trust-ClearBridge Select Fund | 1.22% | 1,594,774 | 36.87M | Jul 30, 2026 |